News
VBRI Researchers Publish Study on Using Extraterrestrial Soil to Treat Hemorrhages in Space
Milwaukee — December 31, 2025
VBRI Researcher Dr. Francesca Ferraresso Named to Forbes 30 Under 30 for Healthcare
Francesca Ferraresso, PhD, a graduate student researcher in the Kastrup Laboratory at Versiti Blood Research Institute (VBRI), is CEO and co-founder of Syrina Therapeutics, a biotech startup developing next-generation RNA technology to treat rare and chronic diseases.
Versiti President and CEO Chris Miskel Named One of Wisconsin’s Most Influential Business Leaders
Versiti is proud to announce that Chris Miskel, president and CEO of Versiti, has been named to BizTimes Media’s Wisconsin 275, an annual publication and list that identifies the most influential business leaders in Wisconsin.

